CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −56,019 | $1.11 | $62K | 616,616 |
| 2026-02-02 | Rucci Carolyn M. SVP, Chief Legal Officer | Sale 10b5-1 | −16,846 | $1.39 | $23K | 641,304 |
| 2026-02-02 | Rucci Carolyn M. SVP, Chief Legal Officer | Sale 10b5-1 | −25,382 | $1.39 | $35K | 615,922 |
| 2026-02-02 | Rucci Carolyn M. SVP, Chief Legal Officer | Sale 10b5-1 | −27,544 | $1.39 | $38K | 588,378 |
| 2026-02-02 | Malabre Richard C SVP, Chief Accounting Officer | Sale 10b5-1 | −36,142 | $1.39 | $50K | 312,772 |
| 2026-02-02 | Malabre Richard C SVP, Chief Accounting Officer | Sale 10b5-1 | −13,382 | $1.39 | $19K | 299,390 |
| 2026-02-02 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −34,951 | $1.39 | $49K | 672,635 |
| 2026-02-02 | Grund Nicholas Chief Commercial Officer | Sale 10b5-1 | −53,585 | $1.39 | $74K | 592,994 |
| 2026-02-02 | Grund Nicholas Chief Commercial Officer | Sale 10b5-1 | −31,244 | $1.39 | $43K | 561,750 |
| 2026-02-02 | Burke Steven Keith SVP, Chief Medical Officer | Sale 10b5-1 | −21,582 | $1.39 | $30K | 994,508 |
| 2026-02-02 | Burke Steven Keith SVP, Chief Medical Officer | Sale 10b5-1 | −25,375 | $1.39 | $35K | 969,133 |
| 2026-02-02 | Burke Steven Keith SVP, Chief Medical Officer | Sale 10b5-1 | −20,701 | $1.39 | $29K | 948,432 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −46,660 | $1.39 | $65K | 3,417,189 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −96,065 | $1.39 | $134K | 3,321,124 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −114,891 | $1.39 | $160K | 3,206,233 |
| 2026-02-02 | Butler John P. CEO and President | Sale 10b5-1 | −83,689 | $1.39 | $116K | 3,297,794 |
| 2025-06-30 | Ostrowski Erik SVP, CFO, CBO & Treasurer | Sale 10b5-1 | −41,314 | $3.67 | $152K | 503,586 |
| 2025-06-09 | Malabre Richard C SVP, Chief Accounting Officer | Sale 10b5-1 | −15,000 | $4.01 | $60K | 266,914 |
| 2025-06-04 | Malabre Richard C SVP, Chief Accounting Officer | Sale 10b5-1 | −13,334 | $3.53 | $47K | 266,914 |
| 2025-03-03 | Butler John P. CEO and President | Sale 10b5-1 | −46,409 | $1.83 | $85K | 2,557,921 |
Page 1 of 6 · 111 trades